<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04900740</url>
  </required_header>
  <id_info>
    <org_study_id>FNO-PICC-03</org_study_id>
    <secondary_id>03/RVO-FNOs/2021</secondary_id>
    <nct_id>NCT04900740</nct_id>
  </id_info>
  <brief_title>Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites</brief_title>
  <official_title>Evaluation of a Tissue Glue SecurePortIV on Prevention of Phlebitis and Migration of PICC and Midline Catheters in Adult Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate a new type of cyanoacrylate tissue glue Secure PortIV on the&#xD;
      insertion site of the PICC (Peripherally inserted central catheter) or Midline catheters.&#xD;
      Fixation of the catheter with the tissue glue should prevent incidents of mechanical and&#xD;
      infective phlebitis as well as external migrations of the catheters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the study, 125 subjects will receive the new tissue glue Secure PortIV and 125 subjects&#xD;
      will be provided standard care. The tissue glue will be applied immediately after insertion.&#xD;
      Evaluation and re-evaluation of the site will be done on the first and seventh day after&#xD;
      insertion using VIP and CLISA (Central-Line Insertion Site Assessment) scale and on the&#xD;
      seventh day with taking a swab from the insertion site; the external length will be measured&#xD;
      on the first and the seventh day, in order to observe the migration or not.&#xD;
&#xD;
      The goal of the study is to evaluate the benefits of the cyanoacrylate tissue glue Secure&#xD;
      PortIV in the prevention of mechanical and infective phlebitis and external migration of the&#xD;
      catheter.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 4, 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The patients will be enrolled into one of two study groups, depending on the decision of the attending physician.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking will be used in the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of mechanical and infective phlebitis</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>The incidence of mechanical and infective phlebitis will be measured in the group with the cyanoacrylate tissue glue in comparison with the standard treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of external migration of the catheter</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>The incidence of external migration of the catheter will be measured in the group with the cyanoacrylate tissue glue in comparison with the standard treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Adult Patients With Mid-term or Long-term Venous Access</condition>
  <arm_group>
    <arm_group_label>Standard care - catheter fixation with surgical stitch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In patients indicated for this type of treatment, as per the attending physician, the catheter will be fixed in the standard way, using a surgical stitch.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental - catheter fixation with glue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In patients indicated for this type of treatment, as per the attending physician, the catheter will be fixed using the glue.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Catheter fixation with surgical stitch</intervention_name>
    <description>The catheter will be fixed using the standard procedure - surgical stitch.</description>
    <arm_group_label>Standard care - catheter fixation with surgical stitch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Catheter fixation with glue (cyanoacrylate tissue glue Secure PortIV)</intervention_name>
    <description>The catheter will be fixed using the experimental procedure - novel surgical glue.</description>
    <arm_group_label>Experimental - catheter fixation with glue</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age&#xD;
&#xD;
          -  need of long-term venous access&#xD;
&#xD;
          -  consent with participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pediatric population&#xD;
&#xD;
          -  not signing the informed consent form&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iveta Constantine, Bc., MSc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiří Hynčica</last_name>
    <phone>0042059737</phone>
    <phone_ext>2587</phone_ext>
    <email>jiri.hyncica@fno.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>708 52</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiří Hynčica</last_name>
      <phone>0042059737</phone>
      <phone_ext>2587</phone_ext>
      <email>jiri.hyncica@fno.cz</email>
    </contact>
    <investigator>
      <last_name>Iveta Constantine, Bc., MSc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Polanská, PhDr., MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Magda Michalíková, DiS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zuzana Figurová</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <reference>
    <citation>Scoppettuolo G, Dolcetti L, Emoli A, La Greca A, Biasucci DG, Pittiruti M. Further benefits of cyanoacrylate glue for central venous catheterisation. Anaesthesia. 2015 Jun;70(6):758. doi: 10.1111/anae.13105.</citation>
    <PMID>25959189</PMID>
  </reference>
  <reference>
    <citation>Di Puccio F, Giacomarro D, Mattei L, Pittiruti M, Scoppettuolo G. Experimental study on the chemico-physical interaction between a two-component cyanoacrylate glue and the material of PICCs. J Vasc Access. 2018 Jan;19(1):58-62. doi: 10.5301/jva.5000816.</citation>
    <PMID>29148010</PMID>
  </reference>
  <reference>
    <citation>Seckold T, Walker S, Dwyer T. A comparison of silicone and polyurethane PICC lines and postinsertion complication rates: a systematic review. J Vasc Access. 2015 May-Jun;16(3):167-77. doi: 10.5301/jva.5000330. Epub 2015 Jan 23. Review.</citation>
    <PMID>25634150</PMID>
  </reference>
  <reference>
    <citation>Gorski LA, Hadaway L, Hagle ME, Broadhurst D, Clare S, Kleidon T, Meyer BM, Nickel B, Rowley S, Sharpe E, Alexander M. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021 Jan-Feb 01;44(1S Suppl 1):S1-S224. doi: 10.1097/NAN.0000000000000396.</citation>
    <PMID>33394637</PMID>
  </reference>
  <reference>
    <citation>Di Giacomo M. Comparison of three peripherally-inserted central catheters: pilot study. Br J Nurs. 2009 Jan 8-21;18(1):8-16. Retraction in: Br J Nurs. 2014 May 8-21;23(9):S25.</citation>
    <PMID>19127226</PMID>
  </reference>
  <reference>
    <citation>Igarashi A, Okuno T, Shimizu T, Ohta G, Ohshima Y. Mechanical stimulation is a risk factor for phlebitis associated with peripherally inserted central venous catheter in neonates. Pediatr Int. 2021 May;63(5):561-564. doi: 10.1111/ped.14476. Epub 2021 May 7.</citation>
    <PMID>32964580</PMID>
  </reference>
  <reference>
    <citation>Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002 Aug 1;20(15):3276-81.</citation>
    <PMID>12149302</PMID>
  </reference>
  <reference>
    <citation>Pinelli F, Balsorano P, Mura B, Pittiruti M. Reconsidering the GAVeCeLT Consensus on catheter-related thrombosis, 13 years later. J Vasc Access. 2021 Jul;22(4):501-508. doi: 10.1177/1129729820947594. Epub 2020 Aug 8.</citation>
    <PMID>32772785</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 13, 2021</study_first_submitted>
  <study_first_submitted_qc>May 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>peripherally inserted central catheter</keyword>
  <keyword>midline</keyword>
  <keyword>cyanoacrylate tissue glue</keyword>
  <keyword>tissue glue</keyword>
  <keyword>phlebitis</keyword>
  <keyword>catheter migration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phlebitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

